Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis

J Lipid Res. 2003 Mar;44(3):470-8. doi: 10.1194/jlr.M200342-JLR200. Epub 2002 Dec 1.

Abstract

Familial hypobetalipoproteinemia (FHBL) subjects may develop fatty liver. Liver fat was assessed in 21 FHBL with six different apolipoprotein B (apoB) truncations (apoB-4 to apoB-89) and 14 controls by magnetic resonance spectroscopy (MRS). Liver fat percentages were 16.7 +/- 11.5 and 3.3 +/- 2.9 (mean +/- SD) (P = 0.001). Liver fat percentage was positively correlated with body mass index, waist circumference, and areas under the insulin curves of 2 h glucose tolerance tests, suggesting that obesity may affect the severity of liver fat accumulation in both groups. Despite 5-fold differences in liver fat percentage, mean values for obesity and insulin indexes were similar. Thus, for similar degrees of obesity, FHBL subjects have more hepatic fat. VLDL-triglyceride (TG)-fatty acids arise from plasma and nonplasma sources (liver and splanchnic tissues). To assess the relative contributions of each, [2H2]palmitate was infused over 12 h in 13 FHBL subjects and 11 controls. Isotopic enrichment of plasma free palmitate and VLDL-TG-palmitate was determined by mass spectrometry. Non-plasma sources contributed 51 +/- 15% in FHBL and 37 +/- 13% in controls (P = 0.02). Correlations of liver fat percentage and percent VLDL-TG-palmitate from liver were r = 0.89 (P = 0.0001) for FHBL subjects and r = 0.69 (P = 0.01) for controls. Thus, apoB truncation-producing mutations result in fatty liver and in altered assembly of VLDL-TG.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Body Mass Index
  • Dietary Fats
  • Fatty Liver / complications*
  • Fatty Liver / genetics
  • Fatty Liver / metabolism*
  • Female
  • Glucose Tolerance Test
  • Humans
  • Hypobetalipoproteinemias / blood
  • Hypobetalipoproteinemias / complications*
  • Hypobetalipoproteinemias / genetics
  • Hypobetalipoproteinemias / metabolism*
  • Insulin Resistance / physiology
  • Lipoproteins, VLDL / metabolism*
  • Liver Diseases / blood
  • Liver Diseases / complications*
  • Liver Diseases / genetics
  • Liver Diseases / metabolism*
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / metabolism
  • Palmitic Acids / administration & dosage
  • Palmitic Acids / blood
  • Palmitic Acids / metabolism
  • Palmitic Acids / pharmacokinetics
  • Severity of Illness Index
  • Triglycerides / metabolism*

Substances

  • Dietary Fats
  • Lipoproteins, VLDL
  • Palmitic Acids
  • Triglycerides